Jiang Xiao-Yun
Department of Pediatrics, the First Affiliated Hospital, SUN Yat-sen University, Guangzhou 510080, China.
Zhonghua Er Ke Za Zhi. 2007 Apr;45(4):272-8.
Primary IgA nephropathy (IgAN) is characterized by a highly variable course ranging from a totally benign condition to rapidly progressive renal failure. About 30% of children with IgAN will eventually have end-stage renal failure after 20 years from onset. A nation-wide survey was conducted and data of hospitalized children (younger than 14 years old) with IgAN during the period of 1995 to 2004 were analyzed. The aim was to investigate the clinical and pathological characteristics, treatment and outcome of the hospitalized children with IgAN.
Questionnaires concerning children with IgAN were designed by the Subspecialty Group of Nephrology, Chinese Society of Pediatrics and distributed to the doctors of 33 hospitals in China. The criterion of IgAN was prominent and diffuse IgA deposition and to a lesser extent, other immunoglobulins in the glomerular mesangium and/or capillary loops, and purpura nephritis, lupus nephritis and hepatic disease were excluded. The data were collected and analyzed.
From January 1, 1995 to December 31, 2004, 1349 hospitalized children were diagnosed as IgAN. The cases of childhood IgAN accounted for 1.37% of the hospitalized cases with urologic-kidney diseases and 11.18% of those who underwent renal biopsies. Complete records were available for 1203 patients. The male to female ratio was 2.07:1. Both the median ages at the disease onset and diagnosis were 9.0 years. The median duration from onset to diagnosis of IgAN was 4 months; 55.94% of patients had predisposing causes, especially infection. Recurrent macroscopic hematuria was the most common clinical manifestation (41.15%), followed by nephritic syndrome (23.77%) and hematuria and proteinuria (20.78%). Subclass III (41.40%) and II (28.51%) were the most common histologic types. The main type of immunofluorescence examination was IgA deposition (34.50%). The intensity of IgA deposition in patients with hematuria and proteinuria and in acute rapidly progressive nephritis was the strongest (+++). There was no unified treatment scheme. Some patients were treated with corticosteroids and immunosuppressants, and 69.24% of the patients with IgAN showed clinical improvement, 10.39% remained unchanged, and 2 cases presented deterioration. The rate of follow-up was 23.35%, the mean duration of follow-up was 24.4 months.
The mean age of onset of the primary childhood IgAN was after 6 years. Hematuria was the most common clinical manifestation. Subclass III and II were the most common histologic type. There was no unified treatment scheme. The rate of follow-up was lower and the rate of lost follow-up was high. It is necessary to establish a normalized management, treatment and follow-up system for childhood IgAN in China.
原发性IgA肾病(IgAN)的病程高度可变,从完全良性状态到快速进展性肾衰竭不等。约30%的IgAN患儿在发病20年后最终会发展为终末期肾衰竭。我们进行了一项全国性调查,并分析了1995年至2004年期间住院的IgAN患儿(年龄小于14岁)的数据。目的是调查住院IgAN患儿的临床和病理特征、治疗及预后情况。
中华医学会儿科学分会肾脏病学组设计了关于IgAN患儿的调查问卷,并分发给中国33家医院的医生。IgAN的诊断标准为肾小球系膜和/或毛细血管袢中显著且弥漫性的IgA沉积,以及程度较轻的其他免疫球蛋白沉积,同时排除紫癜性肾炎、狼疮性肾炎和肝病。收集并分析数据。
1995年1月1日至2004年12月31日,1349例住院患儿被诊断为IgAN。儿童IgAN病例占泌尿系统肾脏疾病住院病例的1.37%,占接受肾活检病例的11.18%。1203例患者有完整记录。男女比例为2.07:1。疾病发病和诊断时的中位年龄均为9.0岁。IgAN从发病到诊断的中位时间为4个月;55.94%的患者有诱发因素,尤其是感染。反复肉眼血尿是最常见的临床表现(41.15%),其次是肾病综合征(23.77%)以及血尿和蛋白尿(20.78%)。Ⅲ型(41.40%)和Ⅱ型(28.51%)是最常见的组织学类型。免疫荧光检查的主要类型是IgA沉积(34.50%)。血尿和蛋白尿患者以及急性快速进展性肾炎患者中IgA沉积强度最强(+++)。没有统一的治疗方案。一些患者接受了糖皮质激素和免疫抑制剂治疗,69.24%的IgAN患者临床症状改善,10.39%无变化,2例病情恶化。随访率为23.35%,平均随访时间为24.4个月。
儿童原发性IgAN的平均发病年龄在6岁以后。血尿是最常见的临床表现。Ⅲ型和Ⅱ型是最常见的组织学类型。没有统一的治疗方案。随访率较低,失访率较高。在中国有必要建立针对儿童IgAN的规范化管理、治疗及随访体系。